DuoBody-EpCAMx4-1BB

N/A

Report date: 2026/03/07 20:00:27

Base Information

Drug NameDuoBody-EpCAMx4-1BB

Drug Alias NameBNT314/GEN1059GEN-1059GEN1059BNT314

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-EpCAMAnti-Tumor necrosis factor receptor superfamily member 9

TargetsEpithelial cell adhesion moleculeTumor necrosis factor receptor superfamily member 9

Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumUnited StatesDenmark +[7]

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBiontech Se Genmab A/S

China Registration ClassN/A

Develop Information

Active CompaniesGenmab A/S Biontech Se

Inactive CompaniesN/A

Active IndicationsSolid tumoursColorectal Neoplasms

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A